e-learning
resources
Barcelona 2010
Tuesday, 21.09.2010
New insights into reactive oxygen species
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Late Breaking Abstract: Paraoxonase 1 activity and protein thiol oxidation in sera of COPD patients
T. Zanic Grubisic, L. Rumora, M. Grdic Rajkovic, G. Puclin, I. Cepelak (Zagreb, Croatia)
Source:
Annual Congress 2010 - New insights into reactive oxygen species
Session:
New insights into reactive oxygen species
Session type:
E-Communication Session
Number:
3718
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
T. Zanic Grubisic, L. Rumora, M. Grdic Rajkovic, G. Puclin, I. Cepelak (Zagreb, Croatia). Late Breaking Abstract: Paraoxonase 1 activity and protein thiol oxidation in sera of COPD patients. Eur Respir J 2010; 36: Suppl. 54, 3718
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Lung function in epidemiological studies from infancy to childhood with focus on urban environment
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Paraoxonase activity in patients with COPD
Source: Annual Congress 2011 - Novel mechanisms in lung injury
Year: 2011
Late Breaking Abstract - Plasma endocan is over-expressed in AECOPD patients: association with lung function decline and apoptosis
Source: International Congress 2018 – Biomarkers of COPD
Year: 2018
Late Breaking Abstract - Reduced activity of energy-transducing NADH-quinone oxidoreductase (complex I) indicates mitochondrial respiratory chain dysfunction in patients with sarcoidosis
Source: International Congress 2018 – Granulomatous disorders: heterogeneous diseases with variable management
Year: 2018
Malanoyl dialdehyde (MDA) and hs-CRP: How are they linked to COPD?
Source: International Congress 2014 – Mechanisms of COPD and inhalation injury
Year: 2014
Monitoring antioxidant enzyme activity in patients with COPD exacerbations
Source: International Congress 2018 – Clinical determinants and biomarkers of COPD
Year: 2018
Late Breaking Abstract: Expression of S100A4 in COPD
Source: Annual Congress 2010 - Novel mechanisms in COPD
Year: 2010
Late Breaking Abstract - Systemic ferritin is an early disease biomarker for silicosis patients
Source: Virtual Congress 2021 – Prognostic markers of disease progression in non-idiopathic pulmonary fibrosis interstitial lung diseases
Year: 2021
Protein oxidation in the diaphragm of patients with COPD
Source: Eur Respir J 2003; 22: Suppl. 45, 358s
Year: 2003
Late Breaking Abstract - Identification of patients with COPD who benefit from benralizumab
Source: International Congress 2019 – ALERT: Abstracts Leading to Evolution in Respiratory Medicine Trials: COPD and cough
Year: 2019
Monitoring oxidative stress in the lung: Changes in superoxide dismutase (SOD) activity during the course of acute exacerbations in COPD
Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations
Year: 2013
Late Breaking Abstract - Efficacy of DPP1 inhibition with brensocatib in subgroups of patients with bronchiectasis- the WILLOW study
Source: Virtual Congress 2020 – ALERT: Infection in adults and children
Year: 2020
Late Breaking Abstract - Intra-alveolar neutrophil-derived microvesicles: a biomarker of COPD severity
Source: International Congress 2018 – Advanced profiling of immune cells in chronic lung diseases
Year: 2018
The glutathione S-transferase (GST) polymorphism and risk for COPD in Brazilian smokers
Source: Eur Respir J 2006; 28: Suppl. 50, 583s
Year: 2006
Late Breaking Abstract - Increased advanced glycation end-products (AGEs) accumulation in skin is a risk factor lung function deterioration in asthmatic patients- preliminary data
Source: International Congress 2019 – Modelling and monitoring of airway diseases
Year: 2019
Late Breaking Abstract - Lack of stability of blood eosinophil counts in patients with COPD.
Source: International Congress 2019 – Blood eosinophils and more in airway diseases
Year: 2019
Role of antioxidant in patients with COPD
Source: Eur Respir J 2001; 18: Suppl. 33, 249s
Year: 2001
Late Breaking Abstract: Cathelicidin has direct anti-rhinoviral activity
Source: Annual Congress 2010 - Cell biology and immunology of lung disease
Year: 2010
Lipid peroxidation and antioxidant enzyme activity in patients with asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 424s
Year: 2002
Late Breaking Abstract - Blood eosinophil count and exacerbation history in COPD: pooled analysis of 24,103 patients
Source: International Congress 2019 – Exacerbations and clinical impact of airway diseases
Year: 2019
Indicators of increased free radical activity in COPD
Source: Eur Respir J 2003; 22: Suppl. 45, 82s
Year: 2003
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept